U.S Physical Therapy Total Assets 2010-2024 | USPH

U.S Physical Therapy total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
U.S Physical Therapy Annual Total Assets
(Millions of US $)
2023 $997
2022 $858
2021 $749
2020 $594
2019 $561
2018 $443
2017 $419
2016 $351
2015 $304
2014 $245
2013 $224
2012 $172
2011 $163
2010 $141
2009 $111
U.S Physical Therapy Quarterly Total Assets
(Millions of US $)
2024-03-31 $1,017
2023-12-31 $997
2023-09-30 $1,010
2023-06-30 $1,000
2023-03-31 $868
2022-12-31 $858
2022-09-30 $800
2022-06-30 $796
2022-03-31 $764
2021-12-31 $749
2021-09-30 $630
2021-06-30 $623
2021-03-31 $598
2020-12-31 $594
2020-09-30 $575
2020-06-30 $585
2020-03-31 $643
2019-12-31 $561
2019-09-30 $565
2019-06-30 $557
2019-03-31 $523
2018-12-31 $443
2018-09-30 $455
2018-06-30 $441
2018-03-31 $418
2017-12-31 $419
2017-09-30 $411
2017-06-30 $417
2017-03-31 $388
2016-12-31 $351
2016-09-30 $310
2016-06-30 $314
2016-03-31 $311
2015-12-31 $304
2015-09-30 $276
2015-06-30 $268
2015-03-31 $257
2014-12-31 $245
2014-09-30 $248
2014-06-30 $241
2014-03-31 $229
2013-12-31 $224
2013-09-30 $180
2013-06-30 $182
2013-03-31 $177
2012-12-31 $172
2012-09-30 $170
2012-06-30 $171
2012-03-31 $164
2011-12-31 $163
2011-09-30 $164
2011-06-30 $147
2011-03-31 $146
2010-12-31 $141
2010-09-30 $127
2010-06-30 $124
2010-03-31 $129
2009-12-31 $111
2009-09-30 $114
2009-06-30 $116
2009-03-31 $119
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.448B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
Quest Diagnostics (DGX) United States $16.369B 16.92
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00